Last reviewed · How we verify
Congenital hyperammonemia, type I
Approved treatments
- Buphenyl · Amgen
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Congenital hyperammonemia, type I patent landscape — cliff calendar, originator estates, attackable patents
- Congenital hyperammonemia, type I treatment landscape brief
- Congenital hyperammonemia, type I treatment updates RSS
Frequently asked questions about Congenital hyperammonemia, type I
What drugs treat Congenital hyperammonemia, type I?
Tracked treatments include Buphenyl.
What is the treatment for Congenital hyperammonemia, type I?
Standard treatment for Congenital hyperammonemia, type I includes Buphenyl. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Congenital hyperammonemia, type I patent cliff · Congenital hyperammonemia, type I CI report
- Treatment: Buphenyl · Amgen
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing